Invivyd Inc

Research Invivyd Inc (IVVD) on Bullrun: market cap USD 278.02M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIVVD
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 278.02M
• Financial periodFY2025
• RevenueUSD 53.43M
• Revenue growth110.5%
• Net income-USD 52.49M
• Free cash flow-USD 58.29M

Valuation Snapshot

latest market cap is USD 278.02M.

About Invivyd Inc

Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand.

Frequently asked questions

What is Invivyd Inc's market cap?

Invivyd Inc's market capitalization is USD 278.02M.

What does Invivyd Inc do?

Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States.